Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration

Hui Dai, Raghavendra S. Navath, Bindu Balakrishnan, Bharath Raja Guru, Manoj K. Mishra, Roberto Romero, Rangaramanujam M. Kannan, Sujatha Kannan

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Aim: Understanding the interactions between nanomaterials and disease processes is crucial for designing effective therapeutic approaches. This article explores the unusual neuroinflammation targeting of dendrimers (with no targeting ligands) in the brain, with significant consequences for nanoscale materials in medicine. Method: The in vivo biodistribution of fluorescent-labeled neutral generation-4- polyamidoamine dendrimers (∼4 nm) in a rabbit model of cerebral palsy was explored following subarachnoid administration. Results: These dendrimers, with no targeting ligands, were localizing in activated microglia and astrocytes (cells responsible for neuroinflammation), even in regions far moved from the site of injection, in newborn rabbits with maternal inflammation-induced cerebral palsy. Conclusion: This intrinsic ability of dendrimers to localize inactivated microglia and astrocytes can enable targeted delivery of therapeutics in disorders such as cerebral palsy, Alzheimer's and multiple sclerosis.

Original languageEnglish
Pages (from-to)1317-1329
Number of pages13
JournalNanomedicine
Volume5
Issue number9
DOIs
Publication statusPublished - 01-11-2010

Fingerprint

Dendrimers
multiple sclerosis
targeting
brain
Brain
Cerebral Palsy
medicine
Disease
ligand
ability
Microglia
interaction
Astrocytes
Ligands
Rabbits
Tuberous Sclerosis
Aptitude
Nanostructures
Nanostructured materials
Multiple Sclerosis

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Bioengineering
  • Biomedical Engineering
  • Development
  • Materials Science(all)

Cite this

Dai, Hui ; Navath, Raghavendra S. ; Balakrishnan, Bindu ; Guru, Bharath Raja ; Mishra, Manoj K. ; Romero, Roberto ; Kannan, Rangaramanujam M. ; Kannan, Sujatha. / Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. In: Nanomedicine. 2010 ; Vol. 5, No. 9. pp. 1317-1329.
@article{064d6e28c88749a5a14d0c6c9b43f90d,
title = "Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration",
abstract = "Aim: Understanding the interactions between nanomaterials and disease processes is crucial for designing effective therapeutic approaches. This article explores the unusual neuroinflammation targeting of dendrimers (with no targeting ligands) in the brain, with significant consequences for nanoscale materials in medicine. Method: The in vivo biodistribution of fluorescent-labeled neutral generation-4- polyamidoamine dendrimers (∼4 nm) in a rabbit model of cerebral palsy was explored following subarachnoid administration. Results: These dendrimers, with no targeting ligands, were localizing in activated microglia and astrocytes (cells responsible for neuroinflammation), even in regions far moved from the site of injection, in newborn rabbits with maternal inflammation-induced cerebral palsy. Conclusion: This intrinsic ability of dendrimers to localize inactivated microglia and astrocytes can enable targeted delivery of therapeutics in disorders such as cerebral palsy, Alzheimer's and multiple sclerosis.",
author = "Hui Dai and Navath, {Raghavendra S.} and Bindu Balakrishnan and Guru, {Bharath Raja} and Mishra, {Manoj K.} and Roberto Romero and Kannan, {Rangaramanujam M.} and Sujatha Kannan",
year = "2010",
month = "11",
day = "1",
doi = "10.2217/nnm.10.89",
language = "English",
volume = "5",
pages = "1317--1329",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "9",

}

Dai, H, Navath, RS, Balakrishnan, B, Guru, BR, Mishra, MK, Romero, R, Kannan, RM & Kannan, S 2010, 'Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration', Nanomedicine, vol. 5, no. 9, pp. 1317-1329. https://doi.org/10.2217/nnm.10.89

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. / Dai, Hui; Navath, Raghavendra S.; Balakrishnan, Bindu; Guru, Bharath Raja; Mishra, Manoj K.; Romero, Roberto; Kannan, Rangaramanujam M.; Kannan, Sujatha.

In: Nanomedicine, Vol. 5, No. 9, 01.11.2010, p. 1317-1329.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration

AU - Dai, Hui

AU - Navath, Raghavendra S.

AU - Balakrishnan, Bindu

AU - Guru, Bharath Raja

AU - Mishra, Manoj K.

AU - Romero, Roberto

AU - Kannan, Rangaramanujam M.

AU - Kannan, Sujatha

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Aim: Understanding the interactions between nanomaterials and disease processes is crucial for designing effective therapeutic approaches. This article explores the unusual neuroinflammation targeting of dendrimers (with no targeting ligands) in the brain, with significant consequences for nanoscale materials in medicine. Method: The in vivo biodistribution of fluorescent-labeled neutral generation-4- polyamidoamine dendrimers (∼4 nm) in a rabbit model of cerebral palsy was explored following subarachnoid administration. Results: These dendrimers, with no targeting ligands, were localizing in activated microglia and astrocytes (cells responsible for neuroinflammation), even in regions far moved from the site of injection, in newborn rabbits with maternal inflammation-induced cerebral palsy. Conclusion: This intrinsic ability of dendrimers to localize inactivated microglia and astrocytes can enable targeted delivery of therapeutics in disorders such as cerebral palsy, Alzheimer's and multiple sclerosis.

AB - Aim: Understanding the interactions between nanomaterials and disease processes is crucial for designing effective therapeutic approaches. This article explores the unusual neuroinflammation targeting of dendrimers (with no targeting ligands) in the brain, with significant consequences for nanoscale materials in medicine. Method: The in vivo biodistribution of fluorescent-labeled neutral generation-4- polyamidoamine dendrimers (∼4 nm) in a rabbit model of cerebral palsy was explored following subarachnoid administration. Results: These dendrimers, with no targeting ligands, were localizing in activated microglia and astrocytes (cells responsible for neuroinflammation), even in regions far moved from the site of injection, in newborn rabbits with maternal inflammation-induced cerebral palsy. Conclusion: This intrinsic ability of dendrimers to localize inactivated microglia and astrocytes can enable targeted delivery of therapeutics in disorders such as cerebral palsy, Alzheimer's and multiple sclerosis.

UR - http://www.scopus.com/inward/record.url?scp=78650070100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650070100&partnerID=8YFLogxK

U2 - 10.2217/nnm.10.89

DO - 10.2217/nnm.10.89

M3 - Article

VL - 5

SP - 1317

EP - 1329

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 9

ER -